We are live on ! Find out more
ACM

Accipiter Capital Management Portfolio holdings

AUM $124M
1-Year Est. Return 6.47%
This Fund
S&P 500
This Quarter Est. Return
-17.15%
1 Year Est. Return
-6.47%
3 Year Est. Return
-55.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$47.9M
AUM Growth
-$10.5M
Cap. Flow
+$66.4K
Cap. Flow %
0.14%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$66.4K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Energy 77.5%
2 Healthcare 22.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FELP
1
DELISTED
Foresight Energy LP
FELP
$37.1M 77.5%
7,622,302
– –
TEVA icon
2
Teva Pharmaceuticals
TEVA
$40.4B
$6.71M 14.02%
202,145
+2,145
+1% +$66.4K
SHPG
3
DELISTED
Shire pic
SHPG
$4.06M 8.48%
24,578
– –

Similar funds

ACM
Akanthos Capital Management Woodland Hills, California $122M AUM 17.6% 1-Year Est. Return
MCM
Mobius Capital Management Pleasanton, California $138M AUM 43.22% 1-Year Est. Return
TCM
Triarii Capital Management Boston, Massachusetts $97.9M AUM 0.4% 1-Year Est. Return
ALIONA
Allianz Life Insurance of North America Minneapolis, Minnesota $91.6M AUM 10.06% 1-Year Est. Return
HA
Hays Advisory Franklin, Tennessee $157M AUM 9.67% 1-Year Est. Return
DFIG
Dragon Financial & Investment Group San Mateo, California $88.2M AUM 7.87% 1-Year Est. Return
PAM
Pope Asset Management Memphis, Tennessee $162M AUM
KC
KHP Capital Tulsa, Oklahoma $164M AUM 7.73% 1-Year Est. Return

Accipiter Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Accipiter Capital Management held 3 positions worth $47.9M, down 18% from $58.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 0%. Accipiter Capital Management opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Energy at 78% of assets, down from 82% a quarter earlier, followed by Healthcare.

  • Accipiter Capital Management added most to Teva Pharmaceuticals in Q2 2017, an estimated $66.4K increase.
  • Accipiter Capital Management's ten largest holdings make up 100% of its $47.9M portfolio in Q2 2017.
  • Accipiter Capital Management opened 0 new positions and closed 0 in Q2 2017.
  • Accipiter Capital Management's portfolio value fell 18% quarter-over-quarter to $47.9M.

Based on Accipiter Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.